Abstract:The rapid increase in antibody demand is urgently calling for high throughput technologies to enhance the efficiency in downstream purification. Membrane chromatography using membrane adsorbents (MAs) has emerged as an attractive alternative. Nevertheless, despite the increasing research efforts made in the past decades, there is a lack of a comprehensive understanding of the structure – chemistry – performance relationship of MAs used in antibody purification, leaving the development of MAs in trial-and-error without a rational guideline. To fill the knowledge gaps, this work focuses on analyzing the key factors influencing the efficiency of bind-and-elute operation of MAs in antibody capture, aiming to bring logics to the choices of membrane materials and structure properties and surface/ligand chemistries in different chromatographic modes. Despite its essential role in antibody binding, the impact of the membrane pore structure was only considered by less than one quarter of the literature. Given a comparatively low antibody binding capacity for affinity MC (roughly in the order of 10–30 mg/ml bed volume), non-affinity types exhibit significant potential but only if the selectivity could be further improved. The common pore size range of the substrates reported in the literature was around 0.2–1 μm, however, when employing surface functionalization, the choices of the functionalization degree and layer thickness were not carefully made, leading to compromised binding and throughput. Scalable fabrication techniques such as electrospinning are investigated in other fields, but are still at the infancy stage for antibody capture applications. Although conventional affinity ligands are well-explored, there is a growing interest to explore alternative and cheaper affinity (e.g., peptides) or non-affinity ligands that can serve in the bind-and-elute of antibodies. With new ligands, it is essential to understand the binding and elution kinetics assisted by mathematical simulations, which however remain under-investigated. Overall, this review provided an in-depth analysis of current developments in research and new thoughts toward designing next-generation membrane chromatography for filling the supply gaps of antibody products.

Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions

Process design and application of twin-column continuous chromatography for antibody affinity separation

Antibody Capture with Twin-Column Continuous Chromatography: Effects of Residence Time, Protein Concentration and Resin

Analysis and Optimal Design of Batch and Two‐column Continuous Chromatographic Frontal Processes for Monoclonal Antibody Purification

Analysis and Optimal Design of Batch and Two-Column Continuous Chromatographic Frontal Processes for Monoclonal Antibody Purification

Model-based Process Development of Continuous Chromatography for Antibody Capture: A Case Study with Twin-Column System

A Novel Twin‐column Continuous Chromatography Approach for Separation and Enrichment of Monoclonal Antibody Charge Variants

Intramodule pressure profiles and protein accumulation during tangential flow filtration

Optimizing particle morphology during antibody precipitation for enhanced tangential flow filtration performance

Deterministic Mathematical Modeling, Sensitivity Analysis, and Dynamic Optimization of Cross-flow Ultrafiltration Systems for Concentration of Monoclonal Antibody Solutions

A Model-Based Performance Analysis of Integrated Chromatography-Ultrafilter Separation Systems for Monoclonal Antibody (mAb) Manufacturing

Explainable Machine Learning Models to Predict Gibbs–Donnan Effect During Ultrafiltration and Diafiltration of High‐Concentration Monoclonal Antibody Formulations

The role of intermolecular interactions on monoclonal antibody filtration through virus removal membranes

Understanding Loss of Soluble High Molecular Weight Species during Filtration of Low Concentration Therapeutic Monoclonal Antibodies

Buffer effects on protein sieving losses in ultrafiltration and their relationship to biophysical properties

Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.

Rapid Concentration of Protein Solution by a Crossflow Electro-Ultrafiltration Process

A review on chromatographic membranes for antibody purification: Factors affecting binding capacity and guidelines for membrane design

Fiber chromatographic enabled process intensification increases monoclonal antibody product yield

Development of temperature-controlled batch and 3-column counter-current protein A system for improved therapeutic purification

A Carrier Phase Ultrafiltration and Backflow Recovery Technique for Purification of Biological Macromolecules